Covington & Burling LLP

Covington & Burling LLP provides comprehensive advice to national and multinational pharmaceutical, biotechnology, diagnostic, and medical device companies across regulatory, transactional, and contentious matters. The firm’s regulatory expertise spans pricing and reimbursement, MHRA guidance, lifecycle management, and marketing authorisations. On the transactional side, the team is experienced in M&A, fundraising, strategic collaborations, and commercial contracts. The practice is led by Grant Castle, a go-to adviser for pharmaceutical and medical device regulations, representing clients in transactions, trade matters, and cases at both European and national levels. Sarah Cowlishaw is at the forefront of digital health, advising on regulatory, compliance, transactional, and commercial matters. Solicitor advocate Brian Kelly is well-placed to handle public and administrative proceedings, investigations, and representation before English and EU courts. Robin Blaney advises on the regulatory aspects of transactions, compliance, and legislative matters, while Winsome Cheung leverages her scientific background to counsel on strategic partnering arrangements.